Earl Martin Douglas's Net Worth
$1.37 Million
Who is Earl Martin Douglas?
Earl Martin Douglas has an estimated net worth of $1.37 Million. This is based on reported shares across multiple companies, which include Allogene Therapeutics, Inc., and BIOMIMETIC THERAPEUTICS, INC..
SEC CIK
Earl Martin Douglas's CIK is 0001362155
Past Insider Trading and Trends
2008 was Earl Martin Douglas's most active year for acquiring shares with 7 total transactions. Earl Martin Douglas's most active month to acquire stocks was the month of December. 2012 was Earl Martin Douglas's most active year for disposing of shares, totalling 18 transactions. Earl Martin Douglas's most active month to dispose stocks was the month of February. 2007 saw Earl Martin Douglas paying a total of $377,700.00 for 40,000 shares, this is the most they've acquired in one year. In 2010 Earl Martin Douglas cashed out on 131,619 shares for a total of $437,354.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Allogene Therapeutics, Inc. (ALLO) Snapshot price: $2.39
SVP, General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.93% | -28.31K |
$2.79 | -$78,843.35 | 449.32K |
Aug 21
| |||
Form 4
| +9.59% | 41.8K |
—
|
—
| 477.63K |
Jan 25
| |||
Form 4
|
∞
| 435.83K |
—
|
—
| 435.83K |
Aug 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BIOMIMETIC THERAPEUTICS, INC. No price found
General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -82.89% | -53.56K |
$2.35 | -$126,056.86 | 11.06K |
Mar 26 - Mar 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 29
| |||
Form 4
| -13.61% | -9.00K |
$3.01 | -$27,078.90 | 57.14K |
Scheduled
|
Oct 12 - Oct 14
| ||
Form 4
| -15.36% | -12.00K |
$2.99 | -$35,937.60 | 66.14K |
Scheduled
|
Oct 6 - Oct 11
| ||
Form 4
| -10.33% | -9.00K |
$2.92 | -$26,271.00 | 78.14K |
Scheduled
|
Oct 3 - Oct 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
| +19.56% | 13.53K |
$8.46 | -$66,493.76 | 82.69K |
Mar 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
| +230.68% | 47.86K |
$7.82 | -$20,565.74 | 68.6K |
Jan 2 - Jan 13
| |||
Form 4
| -6.94% | -1.20K |
$8.45 | -$10,140.00 | 16.1K |
Mar 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
| +110.22% | 8.5K |
$3.63 | $30,855.00 | 16.21K |
Apr 14
| |||
Form 4
| +18.20% | 1K |
$9.05 | $9,050.00 | 6.49K |
Mar 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
| +175.61% | 3.5K |
$15.28 | $53,493.00 | 5.49K |
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |